Pro-Dex Profit Margin 2006-2018 | PDEX

Current and historical gross margin, operating margin and net profit margin for Pro-Dex (PDEX) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Pro-Dex net profit margin as of December 31, 2018 is 12.64%.
Pro-Dex Annual Profit Margins
Pro-Dex Quarterly Profit Margins
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $0.058B $0.022B
Pro-Dex Inc., with operations in Santa Ana, California, Beaverton, Oregon and Carson City Nevada, specializes in bringing speed to market in the development and manufacture of technology-based solutions that incorporate embedded motion control, miniature rotary drive systems and fractional horsepower DC motors, serving the medical, dental, semi-conductor, scientific research and aerospace markets. Pro-Dex's products are found in hospitals, dental offices, medical engineering labs, scientific research facilities, commercial and military aircraft, and high tech manufacturing operations globally.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $66.612B 22.12
McKesson (MCK) United States $23.502B 9.15
Align Technology (ALGN) United States $20.740B 52.81
AmerisourceBergen (ABC) United States $17.113B 12.41
Laboratory Of America Holdings (LH) United States $15.378B 14.15
Cardinal Health (CAH) United States $15.065B 10.15
Cooper (COO) United States $14.545B 25.37
DENTSPLY SIRONA (XRAY) United States $11.005B 24.60
Henry Schein (HSIC) United States $9.160B 14.61
West Pharmaceutical Services (WST) United States $7.847B 37.64
Merit Medical Systems (MMSI) United States $3.277B 35.31
CONMED (CNMD) United States $2.251B 36.68
Patterson (PDCO) United States $2.145B 16.95
STAAR Surgical (STAA) United States $1.642B 137.56
Atrion (ATRI) United States $1.529B 44.87
Antares Pharma (ATRS) United States $0.547B 0.00
Invacare (IVC) United States $0.300B 0.00
Lifevantage (LFVN) United States $0.206B 27.67
Endologix (ELGX) United States $0.074B 0.00
Biolase (BIOL) United States $0.051B 0.00
Retractable Technologies (RVP) United States $0.028B 0.00
Milestone Scientific (MLSS) United States $0.014B 0.00
Aceto (ACET) United States $0.006B 0.00